Dergiler / Anadolu Kardiyoloji Dergisi / 2014 / Cilt: 14 - Sayı: 5

Evaluation of left ventricular functions in patients with pseudoexfoliation syndrome using tissue Doppler echocardiography and its association with plasma BNP levels

Sayfa
422–426
Yayın Tarihi
2022-10-10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Although further studies needed, evaluation and follow-up of PES patients in terms of left ventricular functions will be useful

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Pseudoexfoliation syndrome (PES) is a systemic disorder that involves various visceral organs.
📊
Temel Bulgular & Veri:In this observational cross-sectional study we aimed to investigate the left ventricular functions in patients with PES by using tissue Doppler imaging and correlations between B-type natriuretic peptide levels and cardiac functions.Methods: The study enrolled 22 patients with PES (9 male, 41%), aged 57.0±8.8 years, and 23 control subjects (9 male, 39%), aged 52.8±4.9 years.
💡
Sonuç & Katkı:Although further studies needed, evaluation and follow-up of PES patients in terms of left ventricular functions will be useful
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Pseudoexfoliation syndrome (PES) is a systemic disorder that involves various visceral organs. In this observational cross-sectional study we aimed to investigate the left ventricular functions in patients with PES by using tissue Doppler imaging and correlations between B-type natriuretic peptide levels and cardiac functions.Methods: The study enrolled 22 patients with PES (9 male, 41%), aged 57.0±8.8 years, and 23 control subjects (9 male, 39%), aged 52.8±4.9 years. Patients with any cardiovascular disease were excluded. Fasting blood samples were taken and tissue Doppler imaging was performed at the mitral annulus with echocardiographic examination. The independent t and Mann-Whitney U tests were used.Results: The Em velocities at the basal septum and lateral annulus were significantly lower in patients with PES showing decreased diastolic functions (7.6±2.0 versus 9.1±1.6 cm/s, p=0.01 and 9.3±3.5 versus 11.5±3.1 cm/s, p=0.04 respectively). While global left ventricular systolic function assessed by ejection fraction was not significantly different between patients with PES and controls, the septum S-wave velocities of PES patients were lower (7.6±1.3 versus 8.5±1.2 cm/s, p=0.03). Total plasma BNP levels were significantly higher in PES patients (129.04±99.38 pg/mL versus 59.64±53.69 pg/mL; p=0.005) and there was a negative correlation between plasma BNP concentration and mitral annulus average Em velocities (r=-0.554, p=0.009). E/Em ratio was also significantly higher in PES patients (7.85±2.01 versus 6.64±1.48, p=0.03).Conclusion: In this study we showed decreased left ventricular diastolic functions correlated with plasma BNP levels in PES patients. Although further studies needed, evaluation and follow-up of PES patients in terms of left ventricular functions will be useful

🔖

Bu Makaleye Atıf Yap

YILMAZ, D. Ç., YILMAZ, A., GÖKSEL, İ., CİRİT, A., ŞEN, F., TAMER, L. (2022). Evaluation of left ventricular functions in patients with pseudoexfoliation syndrome using tissue Doppler echocardiography and its association with plasma BNP levels. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 5, 422–426. https://ajindex.com/articles/436074

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001; 45: 265-315. [CrossRef] Naumann GO, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology 1998; 105: 951-68. [CrossRef] Atalar PT, Atalar E, Kılıç H, Abbasoğlu OE, Özer N, Aksöyek S, et al. Impaired systemic endothelial function in patients with pseudoex- foliation syndrome. Int Heart J 2006; 47: 77-84. [CrossRef] Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syn- drome with increased vascular risk. Am J Ophthalmol 1997; 124: 685-7.
  2. Schumacher S, Schlötzer-Schrehardt U, Martus P, Lang W, Naumann GO. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet 2001; 357: 359-60. [CrossRef] Ringvold A, Blika S, Sandvik L. Pseudo-exfoliation and mortality. Acta Ophthalmol Scand 1997; 75: 255-6. [CrossRef] Çıtırık M, Acaroğlu G, Batman C, Yıldıran L, Zilelioğlu O. A possible link between the pseudoexfoliation syndrome and coronary artery disease. Eye 2007; 21: 11-5. [CrossRef] Vessani RM, Ritch R, Liebmann JM, Jofe M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 2003; 136: 41-6. [CrossRef] Bojic L, Ermacora R, Polic S, Ivanisevic M, Mandic Z, Rogosic V, et al. Pseudoexfoliation syndrome and asymptomatic myocardial dysfunc- tion. Graefes Arch Clin Exp Ophthalmol 2005; 243: 446-9. [CrossRef] Demir N, Ulus T, Yücel OE, Kumral ET, Singar E, Tanboğa HI. Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoliation syndrome. Eye 2011; 25: 1177-80. [CrossRef] Ulus T, Nadir A, Yaz YA, Özdemir AO, Mutlu F, Yazıcı HU, et al. Cardiovascular involvement in patients with pseudoexfoliation syn- drome. J Cardiovasc Med (Hagerstown) 2013; 14: 587-92. [CrossRef] Alpaslan M, Karalezli A, Borazan M, Köktekir BE, Müderrisoğlu IH. Decreased aortic root elasticity-as a novel systemic manifestation of the pseudoexfoliation syndrome: an observational study. Anadolu Kardiyol Derg 2012; 12: 483-7.
  3. Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cere- brovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 2000; 129: 83-6. [CrossRef] Tarkkanen A, Reunanen A, Kivelä T. Frequency of systemic vascu- lar diseases in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmol 2008; 86: 598-602. [CrossRef] Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (